Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Quotes

Analysis

Analyst Ratings

News

Press Releases

Twitter

Media Mentions

Ownership

Earnings

DARA Biosciences, Inc. (DARA) 0.72 -0.0372
Price Open:0.7111Day's Range:0.00000 - 1.20000
Price Close:0.73552wk Range:0.00000 - 2.77
Price Day Change:-0.0372Volume:978,060
Price % Change:-5.06Market Cap:17.4M
Bid:0.72000PE Ratio:0
Ask:0.77000EPS Diluted:-0.604
Trade DARA NOW!

The Latest On DARA

Helsinn, DARA Announce U.S. Launch of Gelclair 4/22/13 8:37am
DARA Biosciences Announces Distribution Deal for Gelclair(R), Soltamox(R) 4/3/13 8:03am
DARA Submits KRN5500 to FDA for Orphan Drug Designation 11/29/12 9:17am
Benzinga's Small Cap Movers for Friday November 16, 2012 11/18/12 12:05pm
A Peek Into The Market Before The Trading Starts 10/22/12 7:25am
DARA BioSciences Launches Soltamox in US 10/22/12 6:36am
DARA BioSciences Announces Specialty Oncology Care Platform 9/25/12 7:33am
Benzinga's Microcap Movers for Friday September 14, 2012 9/15/12 8:43pm
Helsinn Says Dara Plans to Introduce Gelclair in Q1 2013 9/13/12 8:34am
DARA BioSciences Announces Soltamox Distribution Partnership in Puerto Rico 8/16/12 8:35am
DARA BioSciences Announces Launch of Bionect for Treatment of Skin Irritation and Burns Associated With Radiation Therapy for Cancer 6/6/12 8:45am
DARA Says COO Now Also President, Drutz Taking CMO, Currently CEO Taking on Title of Medical Chief 5/29/12 8:47am
more
Press Releases
DARA BioSciences Regains Compliance with NASDAQ $1.00 Minimum Bid Price Rule 2/14/13 Business Wire
DARA BioSciences to Present at 15th Annual BIO CEO & Investor Conference 2/11/13 Business Wire
DARA BioSciences to Present at the 6th Annual OneMedForum Conference 1/8/13 Business Wire
DARA BioSciences to Raise $2.8 Million Pursuant to Securities Purchase Agreement 12/31/12 Business Wire
DARA BioSciences Announces Submission of KRN5500 to FDA for Orphan Designation 11/29/12 Business Wire

Get the latest DARA stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for DARA Biosciences, Inc. stock price.

Partner Headlines
Two You Want, One You Don't: SUPN, IMSC, DARA in Focus 11/30/12
DARA Biosciences Inc. Reports Operating Results (10-Q) 11/14/12
One Yes, One No, and One Maybe: DARA, Sarepta, & Synacor Under the Microscope (SYNC, SRPT, DARA) 10/3/12
DARA Biosciences Inc (DARA) CEO David Drutz buys 25,000 Shares 9/18/12
How Close Are These Biotechs to Breakouts? DARA, ZGNX, ANTH in Focus. 9/17/12
DARA Biosciences Inks Deal - Analyst Blog 8/23/12
DARA Biosciences Inc. Reports Operating Results (10-Q) 8/14/12
DARA Biosciences Inc. Reports Operating Results (10-Q) 5/14/12
DARA Bio Starting To Look Interesting - Analyst Blog 5/8/12
DARA Biosciences Inc. Reports Operating Results (10-Q) 11/14/11
DARA's KRN5500 Looking Attractive - Analyst Blog 8/18/11
DARA's KRN5500 Looking Attractive - Analyst Blog 8/18/11